Abstract
This study evaluated the use of real-time continuous glucose monitoring (CGM) versus blood glucose monitoring (BGM) with a glucose meter in pregnant patients with preexisting type 2 diabetes on insulin therapy. The use of CGM improved A1C and reduced infant morbidity and mortality compared with BGM alone.